AVITA Medical Inc (RCEL)
8.495
+0.20
(+2.35%)
USD |
NASDAQ |
Apr 26, 16:00
8.495
0.00 (0.00%)
After-Hours: 20:00
AVITA Medical Cash from Operations (TTM): -38.01M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -38.01M |
September 30, 2023 | -30.58M |
June 30, 2023 | -24.39M |
March 31, 2023 | -18.79M |
December 31, 2022 | -19.09M |
September 30, 2022 | -16.23M |
June 30, 2022 | -17.40M |
Date | Value |
---|---|
March 31, 2022 | -22.46M |
September 30, 2021 | -18.76M |
June 30, 2021 | -25.90M |
March 31, 2021 | -27.87M |
December 31, 2020 | -26.60M |
September 30, 2020 | -25.58M |
June 30, 2020 | -22.75M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-38.01M
Minimum
Dec 2023
-16.23M
Maximum
Sep 2022
-23.89M
Average
-23.57M
Median
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -36.91M |
Retractable Technologies Inc | 2.767M |
Xtant Medical Holdings Inc | -9.515M |
Asensus Surgical Inc | -63.63M |
Catheter Precision Inc | -20.62M |